Biotech, Food & Drug

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization Sort ascending
Feb
25
2014
Angels and Early Exits: Sometimes, a Bird in the Bush is Worth More than a Bird in the Hand Michael Best & Friedrich LLP
Jun
13
2014
Supreme Court Rules that Competitors Can Challenge Advertising that is False or Misleading Even if it Complies with Federal Food and Beverage Labeling Laws Michael Best & Friedrich LLP
Jun
7
2015
Brazil’s New Biodiversity Law Michael Best & Friedrich LLP
May
5
2016
FDA Issues Deeming Rule regarding Tobacco Products Michael Best & Friedrich LLP
Jul
6
2016
Federal Circuit Rules Biosimilar Notice of Commercial Marketing Mandatory Michael Best & Friedrich LLP
Aug
19
2016
FDA Issues Final Rule on Substances Generally Recognized as Safe Michael Best & Friedrich LLP
Mar
12
2011
The USDA Accepting Applications for Biobased Product Label Michael Best & Friedrich LLP
Apr
18
2011
USDA Announces Funding for Blender Pumps Michael Best & Friedrich LLP
Jul
20
2013
Supplementary Protection Certificates and Pediatric Extensions in Croatia Michael Best & Friedrich LLP
Mar
31
2014
EPA (Environmental Protection Agency) Releases Proposed Rule to Clarify Its Jurisdiction Under the Clean Water Act Michael Best & Friedrich LLP
Jul
30
2014
The Race is on! Anxiously Waiting for the First U.S. Biosimilar to Cross the Finish Line Michael Best & Friedrich LLP
Nov
20
2014
A Report from the “Biosimilars and Biotech: MENA Conference” in Istanbul, Turkey: Part 1 Michael Best & Friedrich LLP
Nov
28
2014
Brazil: An Update of the Most Relevant Events for Pharmaceutical Companies in 2014: Part 3 of a 5-Part Series Michael Best & Friedrich LLP
Jun
7
2015
Federal Circuit Hears Oral Arguments in Litigation involving the First U.S. Biosimilar Product Michael Best & Friedrich LLP
Jan
8
2016
January 8, 2016 -- Biologics and Biosimilars Bits and Bytes Michael Best & Friedrich LLP
Nov
13
2010
USPTO Extends and Expands the Green Technology Pilot Program Michael Best & Friedrich LLP
Sep
10
2013
Understanding Biologics and Biosimilars in Brazil Michael Best & Friedrich LLP
May
29
2014
An Overview of Biosimilars in the Russian Federation Michael Best & Friedrich LLP
Jun
13
2014
Cloning: It’s not what you think – Changes to ANVISA’s (Brazil Health Service Agency) “Clone” Procedure Michael Best & Friedrich LLP
Jun
25
2014
Is an Abbreviated Pathway for Biosimilars Coming Soon to China? Michael Best & Friedrich LLP
Feb
6
2015
Is Compulsory Licensing of Generic Medicines Coming to the Russian Federation? Michael Best & Friedrich LLP
Sep
18
2015
Indian Patent Office Rejects Pfizer’s Patent for Tofacitinib – Again! Michael Best & Friedrich LLP
Aug
19
2016
Updates to the Brazilian Food and Drug Administration OTC Drug Guidelines Michael Best & Friedrich LLP
Apr
26
2017
New Guidelines in Brazil Give More Power to ANVISA in Examination of Pharmaceutical Patent Applications Michael Best & Friedrich LLP
Aug
29
2010
States to Re-evaluate Feed-in Tariffs After Recent FERC Ruling Michael Best & Friedrich LLP
Nov
14
2010
EPA Issues Guidance on Permitting for GHG Emissions Michael Best & Friedrich LLP
Jan
18
2011
EPA Defers GHG Permitting Requirements for Biomass Industries Michael Best & Friedrich LLP
Feb
28
2013
High Impact Entrepreneurship in Wisconsin: The Smoke and the Fire Michael Best & Friedrich LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins